Clinical Trials Browser

Suspended × INDUSTRY × Prostatic Neoplasms × Clear all

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT05361915 2024-03-18

Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer

Phase 2 Suspended

100 enrolled

Genitourinary

Prostatic Neoplasms

NCT03970382 2022-08-18

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

Phase 1 Suspended

21 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Melanoma, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT03734575 2019-07-11

ClariCore System Used in Transperineal Prostate Biopsy

Phase NA Suspended

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT01337518 2012-12-18

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

Phase 1 Suspended

150 enrolled

Genitourinary

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

Phase 1 Suspended

54 enrolled

GenitourinaryOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT00909558 2010-02-24

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Phase 1 Suspended

24 enrolled

BreastCNSGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Glioma, Liver Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT00103623 2006-09-19

The Plenaxis® Experience Study

Phase 4 Suspended

2,000 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

Clinical Trials

A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

ClariCore System Used in Transperineal Prostate Biopsy

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

The Plenaxis® Experience Study